Intellisphere Announces Acquisition of Multiple Titles from Ascend Media's Healthcar... ( PLAINSBORO N.J. Feb. 4 /- Intelli...)

Intellisphere Announces Acquisition of Multiple Titles from Ascend Media's Healthcare Division

Date:2/4/2008

PLAINSBORO, N.J., Feb. 4 /PRNewswire/ -- Intellisphere, publisher of the MDNG (MD Net Guide) series of medical magazines and websites, announced today that it has acquired multiple titles from Ascend Media's Healthcare division. The move strengthens the company's presence in several key market segments and demonstrates its commitment to improving quality of life through health research and education while providing new opportunities for associates and innovative options for healthcare marketers.

The assets acquired include the following print publications and affiliated online properties:

-- The American Journal of Managed Care (http://www.ajmc.com)

-- Cardiology Review (http://www.cardiologyreviewonline.com)

-- Pharmacy Times (http://www.pharmacytimes.com)

-- Resident & Staff Physician (http://www.residentandstaff.com)

-- Surgical Rounds (http://www.surgicalroundsonline.com)

-- Family Practice Recertification (http://www.fpronline.com)

-- Internal Medicine World Report (http://www.imwr.com)

-- Physician's Money Digest (http://www.pmdlive.com)

"These are some of the most respected and recognized titles in this market," says Mike Hennessy, Chairman and CEO of MJH & Associates, parent company of Intellisphere, LLC, which assumed control of the new media properties. "This acquisition is a key step in our growth strategy for 2008 and is an exciting opportunity for our company to enhance our print assets while increasing our visibility as an
'/>"/>

SOURCE Intellisphere
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related biology technology :

1. NeoStrata(R) Announces the Launch of PSORENT(TM) Psoriasis Topical Treatment
2. Remergent(R) Announces the Launch of Four New Products Pioneers of DNA Repair Expand Anti-Aging Line
3. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
4. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
5. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
6. Medarex Announces Completion of Sale of Shares in Genmab A/S
7. Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application
8. Rigel Announces Pricing of Public Offering of Common Stock
9. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
10. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
11. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News

Post Your Comments:

(Date:6/19/2013)... June 19, 2013 BioConvergence team ... speaking faculty at 2013’s BioLogistics Summit in San ... coordinated by Cold Chain IQ and IQPC, addressed ... “complexity” is, in part, attributed to current trends ... “Implicit within these trends is an increase in ...

(Date:6/19/2013)... (PRWEB) June 19, 2013 Express Diagnostics ... tests, today announced that it has received Class III ... and sell its DrugCheck® NxStep Onsite Drug Screen ... of the rapid screening device in near-patient settings, such ... Screen Cup received Health Canada Class III approval for ...

(Date:6/18/2013)... China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... preliminary unaudited financial results for the fourth quarter and ... 2013. Fourth Quarter of Fiscal 2013 ... fiscal 2013 increased by 33.3% to RMB133.0 million ($21.4 ...

(Date:6/18/2013)... Philadelphia, PA (PRWEB) June 18, 2013 ... fiber-optic Ball Lenses engineered of synthetic Sapphire and Glass ... stock sizes from Swiss Jewel Company , of ... performance by expanding and collimating the light beams without ... extreme optical clarity and natural durability (9 mohs) make ...

[0] BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment [0] Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors

... (Nasdaq:,PPDI) today announced Daniel G. Darazsdi has been ... on October 1. Mr. Darazsdi, 47, comes ... $34 billion diversified technology and manufacturing,leader, where he ... of finance,transformation and operations. Over the years at ...

... DEERFIELD, Ill., Sept. 12 Baxter,International Inc. (NYSE: ... 2007,Medical Products Industry Leader of the Dow Jones Sustainability ... America Index,(DJSI North America). This marks the ninth consecutive ... and the sixth year the company has been,named Medical ...

... Leading scientists,from around the world will meet ... for producing life-saving vaccines and,antibodies. More than 125 ... Cells for New Vaccines II: Focus on Respiratory ... Pont. The international,scientific workshop is being organized by ...

Cached Biology Technology:PPD Names Daniel Darazsdi as Chief Financial Officer 2 PPD Names Daniel Darazsdi as Chief Financial Officer 3 Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year 2 International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development 2

PPD Names Daniel Darazsdi as Chief Financial Officer Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development

(Date:6/18/2013)... Kingdom, the Energy Department,s National Renewable Energy Laboratory ... published a paper describing a novel cellulose-degrading enzyme ... , commonly known as the gribble. , ... relatively unique ability to produce their own enzymes ... the biomass they eat. New biomass-degrading enzymes from ...

(Date:6/18/2013)... awarded $12.7 million to match nine academic research ... to explore new treatments for patients in eight ... and schizophrenia. The collaborative pilot initiative, called Discovering ... by the National Center for Advancing Translational Sciences ... , The process of developing a new therapeutic ...

(Date:6/18/2013)... a chemical modification of DNA and this modification ... DNA sequence. Until now, scientists believed that this ... genes. Today, a team of researchers from the ... Dermitzakis, Louis-Jeantet Professor at the Faculty of Medicine, ... and that DNA methylation may play both a ...

Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2 NIH to fund collaborations with industry to identify new uses for existing compounds 2 NIH to fund collaborations with industry to identify new uses for existing compounds 3 NIH to fund collaborations with industry to identify new uses for existing compounds 4 The secret of DNA methylation 2

[0] Novel enzyme from tiny gribble could prove a boon for biofuels research [0] NIH to fund collaborations with industry to identify new uses for existing compounds [0] The secret of DNA methylation

... likely occurred some 8 million years ago rather than ... a new statistical model suggests. The revised estimate of ... primate relatives should enable scientists to better interpret the ... of biological anthropology at the Field Museum, and a ...

... 19, 2010 during the United Nations International Year of ... Memorandum of Understanding joining the Convention on Biological Diversity,s ... legally binding treaty with three main goals: conservation of ... and equitable sharing of benefits arising from genetic resources. ...

... ROCKVILLE, Md. -- Members of the American Society ... of plants and their genes, efforts that in addition ... improve our ability to enhance agricultural productivity, grow nutritious ... ASPB members are leading the majority of the ...

New statistical model moves human evolution back 3 million years Missouri Botanical Garden joins convention on biological diversity consortium of scientific partners ASPB members lead new plant genome research program awards

... is designed to allow neomycin/kanamycin selection ... The loxP-PGK-gb2-neo-loxP template encodes the neomycin/kanamycin ... promoter (gb2) for expression of kanamycin ... promoter (PGK) for expression of neomycin ...

These are replacement caps for No. CLS6980 5mm PYREX NMR tubes. Proper method to remove caps is to slice them from the tube. Caps come in eight assorted/mixed colors. Packed in bags of 100....

... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ID ...

Preparation TW--Compatibility: Push-on end cap seals suitable up to 70 C only -Hybridization Tube for Model HB-1D -Comp Dim: 200 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-12...

Biology Products:

loxP flanked, Pro and Euk. Neomycin Selection Cassette (loxP-PGK-gb2-neo-loxP) from Gene Bridges GmbH Corning disposable NMR tube caps, 5mm from Sigma-Aldrich CORNING CELLSTACK CAP, 33MM, PHENOL from Sigma-Aldrich Techne hybridization oven accessories from Sigma-Aldrich